Austin Kulasekararaj, MBBS, MD, MRCP, FRCPath, King’s College Hospital NHS Foundation Trust, London, UK, discusses recent advances and questions in the field of aplastic anemia (AA), commenting on updates from the RACE trial (NCT02099747), the use of eltrombopag and anabolic steroids, as well as the clonal architecture of the disease. This interview took place at the 17th International Congress on Myelodysplastic Syndromes 2023 (MDS 2023) held in Marseille, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.